Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

100.34 +2.19 (+2.23%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Illumina Named to 2021 Dow Jones Sustainability Indices With Highest Score in Pharmaceuticals, Biotechnology and Life Sciences Industry
SOURCE: Illumina 
Via 3BL Media
Topics Stocks
Illumina Salutes Service Members on Veterans Day
SOURCE: Illumina 
Via 3BL Media
Earlier Screening and Aging Population Driving Surging Growth in Colorectal Diagnostics Demand
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – November 11, 2021 – New recommendations for colorectal cancer (CRC) screening by both the US Preventative Services Task Force... 
Via FinancialNewsMedia
Bioinformatics Market Worth $21.8 Billion by 2026 - Size, Industry Trends, Key Players and Forecast
Northbrook, IL -- (SBWIRE) -- 11/10/2021 -- Bioinformatics Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business Grow. 
Via SBWire
Illumina Named Best for Vets Employer
SOURCE: Illumina 
Via 3BL Media
Topics Supply Chain
Illumina Named to Forbes World's Best Employer List
SOURCE: Illumina 
Via 3BL Media
Illumina Recognized As #20 on Fortune's Change the World List
SOURCE: Illumina 
Via 3BL Media
"Pharmacogenomics Saved My Life"
SOURCE: Illumina 
Via 3BL Media
Topics Product Recall
Illumina Clocks 40% Growth In Q3; Earnings Beat Expectations
Illumina Inc (NASDAQ: ILMN) reported Q3 revenues of $1.11 billion, +40% Y/Y, beating the consensus of $1.04 billion. Consolidated Product revenues were $978 million,... 
Via Benzinga
Topics Earnings
Illumina, inc (ILMN) Q3 2021 Earnings Call Transcript
ILMN earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
After Its Grail Buyout, Illumina Beats Third-Quarter Expectations
Illumina stock inched higher late Thursday after the company beat forecasts. 
Via Investor's Business Daily
Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative
SOURCE: Illumina 
Via 3BL Media
Illumina Named a World's Top-Female Friendly Company by Forbes
SOURCE: Illumina 
Via 3BL Media
NASDAQ: ILMN Investor Notice: Investigation over Potential Wrongdoing at Illumina, Inc.
San Diego, CA -- (SBWIRE) -- 10/29/2021 -- An investigation on behalf of investors in Illumina, Inc. (NASDAQ: ILMN) shares over potential wrongdoing at Illumina, Inc. was announced. 
Via SBWire
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... 
Via Benzinga
Sequencing to Save the Lemurs: A Collaboration Between the San Diego Zoo Wildlife Alliance and Illumina
SOURCE: Illumina 
Via 3BL Media
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Microfluidics Market Worth $58.8 Billion by 2026 - Size, Share, Growth and Trend Analysis Report
Northbrook, IL -- (SBWIRE) -- 10/28/2021 -- According to the new market research report "Microfluidics Market by Product (Devices, Components (Chip, Sensor, Pump, Valve)), Application (IVD (POC,... 
Via SBWire
Illumina Supports Israel's National Program to Accelerate Diagnoses of Critically-Ill Newborns with Suspected Genetic Disease
SOURCE: Illumina 
Via 3BL Media
Next-Generation Sequencing: Helping to Better Understand the Impact of Climate Change in Our Future
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change
Single-Cell Analysis Market Worth $6.3 Billion by 2026 - Emerging Trends, Top Growing Segments and Future Indusrtry Developments
Northbrook, IL -- (SBWIRE) -- 10/26/2021 -- Single-cell Analysis Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business... 
Via SBWire
'Halftime Report' Final Trades From Oct. 25: Illumina, JPMorgan, And More
On CNBC’s "Halftime Report" f... 
Via Benzinga
Companion Diagnostics Market : Industry-Specific Challenges, Opportunities and Trends Affecting the Growth
Northbrook, IL -- (SBWIRE) -- 10/21/2021 -- Companion Diagnostics Market Research Report Gives in Detailed Analysis of Industry Segments, Opportunities, Growth and Size That Will Help Your Business... 
Via SBWire
Illumina to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021
SOURCE: Illumina 
Via 3BL Media
Illumina Commits to 100 Percent Clean, Renewable Energy from San Diego Community Power
SOURCE: Illumina 
Via 3BL Media
Topics Climate Change Economy Emissions
Bet On Biopharma: Data, Digitization, Discovery
The after-effects of pandemic-era policies will be with us for some time — with many supply chains still experiencing significant disruption. The worst of this “scarring” will heal. But the... 
Via Talk Markets
Illumina Insider Sold $1.2M In Company Stock
Alexander Aravanis, SVP And Chief Technology Officer at Illumina (NASDAQ:ILMN), made a large insider sell on October 12, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Illumina Launches New Employee Resource Group iLatinx During Hispanic Heritage Month
SOURCE: Illumina 
Via 3BL Media
Cancer Profiling Market Worth $13.9 Billion by 2025 – Key Players are Illumina, Inc. (US), QIAGEN N.V. (Germany), NeoGenomics Laboratories, Inc. (US)
Via AB Newswire
Global Nuclease Market: What Are the Key Trends in Market? with Top Companies Like: MercK, Illumina, Thermo Fisher Scientific
The global Nuclease market is extensively evaluated by seasoned research analysts to help readers to expand their market knowledge and become aware of future market changes ahead of time. 
Via SBWire
Topics Initial Public Offering
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.